menu_open
Columnists Actual . Favourites . Archive
We use cookies to provide some features and experiences in QOSHE

More information  .  Close
Aa Aa Aa
- A +

British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance

14 6
30.10.2024
GSK suffered a loss after tax of £58 million ($75 million) in the July-September period compared with net profit of £1.5 billion one year earlier.

© Fortune


Get it on Google Play